The Racing Medication and Testing Consortium proposes modification affecting clenbuterol use in thoroughbred racing (it is already a prohibited substance for Quarter horse races). Essentially, the RMTC proposes: 1) eliminating the thresholds for clenbuterol and move to a LOD policy for this drug; 2) adopt the CPMA’s recommended withdrawal guidance of 28 days; 3) Regulate…
The USTA has proposed to amend ARCI-024-010 DECLARATIONS AND DRAWING (C)(4) Qualifying Races in regard to the use of hopples. The RCI Standardbred Racing Committee reviewed the proposal on August 17, 2020 and without objection recommends full approval as submitted by the Model Rules Committee the the ARCI Board/Membership.
The USTA has proposed to amend ARCI-021-020 FACILITIES AND EQUIPMENT (D)(5)(6) Racetrack to add racetrack maintenance guidelines. The RCI Standardbred Racing Committee met on August 17, 2020 and reviewed the proposal and has unanimously recommended that the Model Rules Committee and ultimate the RCI Board/Membership adopt the proposal without change.
Update: July 2, 2020. The Model Rules Committee met and considered the committee proposal and based upon items raised as to certain language contained in the committee proposal, the proposed rule was remanded to the Pari-Mutuel Auditors Committee to address whatever technical matters need to be clarified. It is anticipated that this will be considered…
UPDATE: August 24, 2020 – Following the July 28, 2020 roundtable discussion on this issue, an working session of regulators met on August 6, 2020 to provide guidance to RCI staff to develop a draft rule to be presented to the Model Rules Committee. The draft represents the direction given following the webinar and the…
UPDATE: July 3, 2020 – This matter is open for industry comment. Comments should be directed to rules@arci.com. A special meeting of the Model Rules Committee will be convened to discuss this in early August, 2020. UPDATE: On March 12, 2020, the Drug Testing Standards and Practices Committee made final recommendations on revisions to the…
UPDATE: August 12, 2020. – The USTA’s Harness Racing Medication Collaborative has formally re-submitted three proposed Model Rule modifications dealing with Clenbuterol, Betamethasome, and Methylprednisolone policy in standardbred racing only. The ARCI Scientific Advisory Group will meet to consider this matter on August 28, 2020. BACKGROUND: The ARCI Scientific Advisory Group has previously assessed clenbuterol…